Los Angeles Capital Management LLC Trims Holdings in Utah Medical Products, Inc. (NASDAQ:UTMD)

Los Angeles Capital Management LLC lowered its position in Utah Medical Products, Inc. (NASDAQ:UTMD) by 22.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 23,678 shares of the medical instruments supplier’s stock after selling 6,875 shares during the period. Los Angeles Capital Management LLC owned approximately 0.70% of Utah Medical Products worth $1,455,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently bought and sold shares of UTMD. Golden State Wealth Management LLC purchased a new stake in shares of Utah Medical Products in the 4th quarter valued at $31,000. R Squared Ltd acquired a new position in Utah Medical Products during the fourth quarter valued at $49,000. BNP Paribas Financial Markets boosted its holdings in Utah Medical Products by 102.7% in the third quarter. BNP Paribas Financial Markets now owns 1,117 shares of the medical instruments supplier’s stock valued at $75,000 after purchasing an additional 566 shares during the last quarter. SG Americas Securities LLC acquired a new stake in Utah Medical Products during the 4th quarter worth about $157,000. Finally, Virtu Financial LLC purchased a new position in shares of Utah Medical Products during the 3rd quarter valued at about $207,000. Institutional investors and hedge funds own 69.60% of the company’s stock.

Analyst Ratings Changes

Separately, StockNews.com downgraded Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research note on Thursday, November 7th.

Utah Medical Products Price Performance

Shares of NASDAQ UTMD opened at $59.61 on Friday. The firm’s 50 day simple moving average is $61.20 and its 200-day simple moving average is $64.21. Utah Medical Products, Inc. has a 12 month low of $58.87 and a 12 month high of $77.33. The stock has a market capitalization of $202.20 million, a price-to-earnings ratio of 15.09 and a beta of 0.08.

Utah Medical Products (NASDAQ:UTMD) last released its quarterly earnings results on Tuesday, January 28th. The medical instruments supplier reported $0.86 EPS for the quarter. Utah Medical Products had a net margin of 33.92% and a return on equity of 11.07%.

Utah Medical Products Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, April 3rd. Investors of record on Friday, March 14th will be paid a $0.305 dividend. The ex-dividend date is Friday, March 14th. This represents a $1.22 annualized dividend and a dividend yield of 2.05%. Utah Medical Products’s dividend payout ratio is presently 30.89%.

Utah Medical Products Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.